This marks U.S. News & World Report's first-ever evaluation of home health providers nationwide, identifying top-performing ...
Q4 2025 net product revenue for ZORYVE® (roflumilast) was $127.5 million, an 84% increase compared to Q4 2024, and a 29% increase compared to Q3 2025Full year 2025 net product ...
FGFs are established as key players during neural induction and also during the induction of ectodermal placodes and possibly the neural crest. FGFs are utilised in the posteriorization of the neural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results